Nucleic Acid Purification via Direct Silica Binding

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current nucleic acid purification methods involving phenol-based reagents face challenges in efficiently separating nucleic acids from proteins and lipids without contaminating downstream processes, as phenol is toxic and requires labor-intensive phase separation and centrifugation steps.

Innovation Solution

A method involving binding nucleic acid molecules to a silica substrate using chaotropic salts and alcohols, allowing direct binding from an organic suspension without separating phases or centrifugation, utilizing denaturing solvents like phenol and chaotropic agents to facilitate purification.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If phenol-based reagents are used to separate nucleic acids from proteins and lipids, then nucleic acid purification is achieved, but phenol contamination interferes with downstream processes and requires labor-intensive phase separation and centrifugation steps

Engineering Contradiction:
Improvenucleic acid purification efficiencyVSAvoidphase separation and centrifugation steps
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent extracts and removes the harmful phenol component from the purification process while retaining its useful function of denaturing proteins and solubilizing lipids. By using alternative binding agents that do not require phenol removal, the method eliminates the need for complex phase separation and centrifugation steps, directly addressing the contradiction between purification efficiency and process complexity

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent introduces alternative binding agents as intermediaries between the nucleic acid and the silica substrate. These binding agents facilitate direct binding without requiring phenol-based reagents, thereby eliminating the need for subsequent phenol removal steps and simplifying the overall purification process

Inventive Principle:
Principle #24Intermediary (Mediator)

2Ease of manufacture

If phenol-based reagents are used for nucleic acid purification, then proteins and lipids are solubilized, but phenol is toxic and requires careful removal to avoid interfering with downstream processes

Engineering Contradiction:
Improveprotein and lipid solubilizationVSAvoidphenol toxicity and interference with downstream processes
Core Design Contradiction:
Ease of manufactureVSObject-affected harmful factors

Solution Approach 1:

The patent converts the harmful phenol component into a beneficial denaturing solvent by using alternative binding agents that achieve the same protein denaturation and lipid solubilization effects without phenol toxicity. The method maintains the useful functions while eliminating the harmful effects, allowing direct binding without phenol removal

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Solution Approach 2:

The patent changes the chemical parameters of the binding agent composition to eliminate phenol while maintaining effective nucleic acid binding. By adjusting the chemical composition and properties of the binding agent, the method achieves the same purification outcomes without the toxic effects of phenol, enabling direct binding from organic suspensions

Inventive Principle:
Principle #35Parameter changes

3Reliability

If traditional phenol-based purification methods are used, then nucleic acids are separated from contaminants, but labor-intensive steps are required and throughput is limited

Engineering Contradiction:
Improvenucleic acid separation from contaminantsVSAvoidpurification throughput
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent merges multiple separation steps into a single direct binding operation. By combining the denaturation, solubilization, and binding functions into one step using alternative binding agents, the method eliminates the need for separate phase separation and centrifugation steps, thereby increasing throughput while maintaining separation reliability

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The patent replaces the mechanical separation system (centrifugation and phase separation) with a chemical binding system. By using alternative binding agents that enable direct binding to silica substrates, the method substitutes mechanical separation operations with chemical interactions, eliminating labor-intensive steps and increasing productivity

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method efficiently purifies nucleic acids by reducing labor and minimizing phenol contamination, enabling high-throughput nucleic acid purification with reduced exposure to nuclease activity and contamination, suitable for both DNA and RNA purification.

Implementation Method 1

a binding agent comprising a chaotropic salt, an alcohol or a combination thereof

Methodology Applied
Scientific EffectChaotropic effect:

Implementation Method 2

contacting the sample to a silica substrate... thereby binding the nucleic acid molecule to the silica substrate

Methodology Applied
Scientific EffectAdsorption: Adsorption

Implementation Method 3

organic solvents, such phenol, have been widely used to solubilize proteins and lipids associated with nucleic acids into an organic phase

Methodology Applied
Scientific EffectPhase separation:

Implementation Method 4

Once denatured, proteins are typically highly hydrophobic, while nucleic acids remain hydrophilic

Methodology Applied
Scientific EffectHydrophobicity: Hydrophobe

Data Source

PatentUS10464961B2Nucleic acid purification
Publication Date: 2019.11.05 ZYMO RESEARCH CORP
  • US10464961B2 patent drawing
  • US10464961B2 patent drawing
  • US10464961B2 patent drawing

AI summary

Methods and composition for nucleic acid isolation are provided. In one embodiment, the invention provides a method for nucleic acid purification from biological samples extracted with phenol-based denaturing solvents, which does not require phase separation or nucleic acid precipitation. Methods according to the invention may also be used for differential isolation of RNA and DNA.